AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Caissargues, June 9, 2025
Bastide Groupe announced today the disposal of its French subsidiaries, Cicadum, 51%-owned, (signing subject to financing condition precedent) and Medsoft, 100%-owned, both specialized in stomatherapy. The two subsidiaries have been sold to their founders.
In 2023-2024 fiscal year, Cicadum and Medsoft generated combined revenue of €11 million.
The transaction, settled in cash, will have an accretive impact on the Group's margins and will contribute to reducing Bastide Groupe's net debt. The Group continues to assess potential divestments of assets that no longer align with its strategy or that could unlock the value created by the Group.
NEXT PUBLICATION:
2024-2025 annual revenue on Thursday, September 4, 2025 after the close of trading.
A propos de Groupe Bastide Le Confort Médical
Créé en 1977 par Guy Bastide, le Groupe Bastide est l'un des principaux acteurs européens dans la prestation de santé à domicile. Présent dans 8 pays, Bastide développe une démarche qualité permanente et s'engage à fournir les dispositifs médicaux et les services associés répondant le mieux aux besoins des patients dans les domaines clés de la santé : diabète, nutrition, perfusion, respiratoire, stomathérapie et urologie. Bastide est coté sur Euronext Paris (ISIN : FR0000035370, Reuters BATD.PA, - Bloomberg BLC: FP).
CONTACTS
| Groupe Bastide | Actus Finance | |
| Vincent Bastide/Olivier Jourdanney T. +33 (0)4 66 38 68 08 www.bastide-groupe.fr | Analystes-Investisseurs Hélène de Watteville T. +33 (0)1 53 67 36 33 | Presse – Médias Déborah Schwartz T. +33 (0)1 53 67 36 35 |
About Groupe Bastide Le Confort Médical
Created in 1977 by Guy Bastide, Groupe Bastide is a leading European provider of home healthcare services. Present in eight countries, Bastide develops a permanent quality approach and is committed to providing medical devices and associated services that best meet patients' needs in key health areas: diabetes, nutrition, infusion, respiratory care, stomatherapy and urology. Bastide is listed on Euronext Paris (ISIN: FR0000035370, Reuters BATD.PA, - Bloomberg BLC: FP).
CONTACTS
| Groupe Bastide | Actus Finance | |
| Vincent Bastide/Olivier Jourdanney T. +33 (0)4 66 38 68 08 www.bastide-groupe.fr | Analyst-Investor Hélène de Watteville T. +33 (0)1 53 67 36 33 | Press – Media Déborah Schwartz T. +33 (0)1 53 67 36 35 |
- SECURITY MASTER Key: mpueYsacZGqcx3GeZ5drbpaXbJxllWaaamrLxWdxmMmVnJxoxWuWnJuWZnJjlmpo
- Check this key: https://www.security-master-key.com.
Regulated information:
Inside Information:
- other releases
Full and original press release in PDF: https://www.actusnews.com/news/92152-cession-cicadum-et-medsoft-veng.pdf
